102 related articles for article (PubMed ID: 2120769)
1. 51Cr-ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug.
Aabakken L; Osnes M
Scand J Gastroenterol; 1990 Sep; 25(9):917-24. PubMed ID: 2120769
[TBL] [Abstract][Full Text] [Related]
2. Cr-ethylenediaminetetraacetic acid absorption test. Methodologic aspects.
Aabakken L
Scand J Gastroenterol; 1989 Apr; 24(3):351-8. PubMed ID: 2499921
[TBL] [Abstract][Full Text] [Related]
3. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios.
Oman H; Henriksson AE; Johansson SG; Blomquist L
Scand J Gastroenterol; 1996 Dec; 31(12):1182-8. PubMed ID: 8976010
[TBL] [Abstract][Full Text] [Related]
4. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract.
Aabakken L; Larsen S; Osnes M
Scand J Rheumatol; 1989; 18(6):361-8. PubMed ID: 2515593
[TBL] [Abstract][Full Text] [Related]
5. Relationship between small-intestinal transit rate and intestinal absorption of (14)C-labelled mannitol and (51)Cr-labelled ethylenediaminetetraacetic acid in healthy subjects.
Madsen JL; Scharff O; Rabol A; Krogsgaard OW
Scand J Gastroenterol; 1996 Mar; 31(3):254-9. PubMed ID: 8833355
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non-steroidal, anti-inflammatory drugs.
Aabakken L; Larsen S; Osnes M
Scand J Rheumatol; 1989; 18(6):369-75. PubMed ID: 2515594
[TBL] [Abstract][Full Text] [Related]
7. Increased intestinal marker absorption due to regional permeability changes and decreased intestinal transit during sepsis in the rat.
Wang Q; Pantzar N; Jeppsson B; Weström BR; Karlsson BW
Scand J Gastroenterol; 1994 Nov; 29(11):1001-8. PubMed ID: 7871365
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives.
Ainsworth M; Eriksen J; Rasmussen JW; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1989 Oct; 24(8):993-8. PubMed ID: 2512633
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change.
Jenkins AP; Nukajam WS; Menzies IS; Creamer B
Scand J Gastroenterol; 1992 Sep; 27(9):769-73. PubMed ID: 1411284
[TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model.
Davies NM; Wright MR; Jamali F
Pharm Res; 1994 Nov; 11(11):1652-6. PubMed ID: 7870685
[TBL] [Abstract][Full Text] [Related]
11. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man.
Oman H; Blomquist L; Henriksson AE; Johansson SG
Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970
[TBL] [Abstract][Full Text] [Related]
12. Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis.
Ramage JK; Stanisz A; Scicchitano R; Hunt RH; Perdue MH
Gastroenterology; 1988 Jun; 94(6):1368-75. PubMed ID: 3129330
[TBL] [Abstract][Full Text] [Related]
13. Application of the 51Cr-EDTA urinary recovery test for assessment of intestinal permeability in the horse.
Escala J; Gatherer ME; Voûte L; Love S
Res Vet Sci; 2006 Apr; 80(2):181-5. PubMed ID: 16143355
[TBL] [Abstract][Full Text] [Related]
14. Intestinal permeability to [51Cr]EDTA in infectious diarrhea.
Zuckerman MJ; Watts MT; Bhatt BD; Ho H
Dig Dis Sci; 1993 Sep; 38(9):1651-7. PubMed ID: 8359077
[TBL] [Abstract][Full Text] [Related]
15. Intestinal permeability to 51Cr-labelled ethylenediaminetetraacetate in food-intolerant subjects.
Scadding G; Bjarnason I; Brostoff J; Levi AJ; Peters TJ
Digestion; 1989; 42(2):104-9. PubMed ID: 2504639
[TBL] [Abstract][Full Text] [Related]
16. The X-ray contrast medium iodixanol detects increased colonic permeability equally well as 51Cr-labeled ethylenediaminetetraacetic acid in experimental colitis of rats.
Andersen R; Hosaka J; Halstensen TS; Stordahl A; Tverdal A; Aabakken L; Laerum F
Scand J Gastroenterol; 1996 Feb; 31(2):140-6. PubMed ID: 8658036
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of increased intestinal [51Cr]EDTA absorption during experimental colitis in the rat.
Pantzar N; Ekström GM; Wang Q; Weström BR
Dig Dis Sci; 1994 Nov; 39(11):2327-33. PubMed ID: 7956599
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between fecal blood loss and drug-induced gastric mucosal lesions.
Hedenbro JL; Wetterberg P; Vallgren S; Bergqvist L
Gastrointest Endosc; 1988; 34(3):247-51. PubMed ID: 3391380
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal blood loss during treatment with naproxen for rheumatoid arthritis.
van den Ouweland FA; Corstens FH; van de Putte LB; Gribnau FW
Scand J Rheumatol; 1987; 16(5):365-70. PubMed ID: 3500510
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy.
Bjarnason I; Smethurst P; Levi AJ; Peters TJ
Gut; 1985 Jun; 26(6):579-85. PubMed ID: 3924747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
